Scancell (LON:SCLP) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

Scancell Holdings plc (LON:SCLP) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 12.24 ($0.16) and traded as low as GBX 8.10 ($0.11). Scancell shares last traded at GBX 8.50 ($0.11), with a volume of 329,311 shares changing hands.

Scancell Price Performance

The firm has a market capitalization of £88.04 million, a P/E ratio of -13.03 and a beta of 0.35. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The company has a 50 day moving average of GBX 9.15 and a 200-day moving average of GBX 12.24.

Scancell (LON:SCLP) last posted its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. On average, sell-side analysts predict that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.